enow.com Web Search

  1. Ads

    related to: alzheimer's over the counter medication

Search results

  1. Results from the WOW.Com Content Network
  2. Alzheimer's: Are newly approved drugs making a real-life ...

    www.aol.com/alzheimers-newly-approved-drugs...

    Over the past few years, the Food and Drug Administration has approved various new treatments for Alzhimer's disease, but are they making a real difference? This Special Feature investigates.

  3. Memantine - Wikipedia

    en.wikipedia.org/wiki/Memantine

    Memantine, sold under the brand name Namenda among others, is a medication used to slow the progression of moderate-to-severe Alzheimer's disease. [10] [11] [8] It is taken by mouth. [10] [8] Common side effects include headache, constipation, sleepiness, and dizziness. [10] [11] Severe side effects may include blood clots, psychosis, and heart ...

  4. A Revolutionary New Alzheimer’s Drug Was Just Approved by the ...

    www.aol.com/revolutionary-alzheimer-drug-just...

    Lecanemab (a.k.a. leqembi) has received full approval from the U.S. Food and Drug Administration. This is the first FDA-approved treatment to help slow the progression of Alzheimer’s disease.

  5. Making sense of controversy over the new Alzheimer’s drug - AOL

    www.aol.com/news/making-sense-controversy-over...

    The medication has shown some promise at addressing what may be an ... At the core of the controversy over aducanumab is a broader debate over what causes Alzheimer’s disease and how it might ...

  6. Glycerophosphorylcholine - Wikipedia

    en.wikipedia.org/wiki/Glycerophosphorylcholine

    It is also a parasympathomimetic acetylcholine precursor [1] which has been investigated for its potential for the treatment of Alzheimer's disease [2] and other dementias. [3] Alpha-GPC rapidly delivers choline to the brain across the blood–brain barrier and is a biosynthetic precursor of acetylcholine. [2] It is a non-prescription drug in ...

  7. RespireRx - Wikipedia

    en.wikipedia.org/wiki/RespireRx

    In February 2005, Cortex received U.S. Food and Drug Administration approval to begin Phase II clinical trials for CX717 for use as a treatment for Alzheimer’s, ADHD and Sleep disorders. [1] In 2006, The FDA halted clinical trials for CX717 because they feared the drug was toxic. They later allowed testing to continue but at doses too low to ...

  1. Ads

    related to: alzheimer's over the counter medication